ES2074981T3 - Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos. - Google Patents
Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos.Info
- Publication number
- ES2074981T3 ES2074981T3 ES87311079T ES87311079T ES2074981T3 ES 2074981 T3 ES2074981 T3 ES 2074981T3 ES 87311079 T ES87311079 T ES 87311079T ES 87311079 T ES87311079 T ES 87311079T ES 2074981 T3 ES2074981 T3 ES 2074981T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- disorders
- cognoscitive
- cyclic derivatives
- hetero cyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ESTA INVENCION SE REFIERE AL EMPLEO DE COMPUESTOS QUE ACTUAN COMO ANTAGONISTAS DE 5-HIDROXITRIPTAMINA (5-HT) EN RECEPTORES DE 5-HT3, PARA EL TRATAMIENTO DE DESORDENES DE LA COGNICION TALES COMO DISMINUCION DE LA ATENCION Y DE LA MEMORIA Y ESTADOS DEMENCIALES.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868630074A GB8630074D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB868630077A GB8630077D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB868630076A GB8630076D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB878707175A GB8707175D0 (en) | 1987-03-25 | 1987-03-25 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2074981T3 true ES2074981T3 (es) | 1995-10-01 |
Family
ID=27449858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87311079T Expired - Lifetime ES2074981T3 (es) | 1986-12-17 | 1987-12-16 | Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4985437A (es) |
EP (3) | EP0279990B1 (es) |
JP (1) | JP2608079B2 (es) |
AT (2) | ATE152623T1 (es) |
DE (2) | DE3752062T2 (es) |
ES (1) | ES2074981T3 (es) |
GR (1) | GR3017369T3 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0279114B2 (en) * | 1986-11-21 | 1995-08-23 | Glaxo Group Limited | Medicaments for the treatment or prevention of the withdrawal syndrome |
US5198447A (en) * | 1986-11-21 | 1993-03-30 | Glaxo Group Limited | Medicaments |
GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
WO1990014347A1 (en) * | 1989-05-24 | 1990-11-29 | Nippon Shinyaku Co., Ltd. | Indole derivatives and medicine |
US5171745A (en) * | 1990-07-13 | 1992-12-15 | Du Pont Merck Pharmaceutical Company | Method of treating neurological dysfunction using neutrotransmitter enhancers |
DE69111816T4 (de) * | 1990-08-31 | 1996-08-01 | Nippon Shinyaku Co Ltd | Indolederivate und ihre verwendung als serotonin-antagoniste. |
HU211081B (en) * | 1990-12-18 | 1995-10-30 | Sandoz Ag | Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same |
EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
IT1250629B (it) * | 1991-07-04 | 1995-04-21 | Boehringer Ingelheim Italia | Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. |
US5607938A (en) * | 1993-03-08 | 1997-03-04 | Fujisawa Pharmaceutical Co., Ltd. | Medicament for treating or preventing cerebrovascular infarction |
GB9412995D0 (en) * | 1994-06-28 | 1994-10-26 | Prendergast Kenneth F | Safety enhancing pharmaceutical compositions of an active indazole |
AR036041A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
BR0212477A (pt) * | 2001-09-12 | 2004-08-24 | Upjohn Co | 7-aza[2.2.1] bicicloheptanos substituìdos para o tratamento de doenças |
HUP0402289A2 (hu) | 2001-10-02 | 2005-02-28 | Pharmacia & Upjohn Company | Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
EP1476448A2 (en) * | 2002-02-19 | 2004-11-17 | PHARMACIA & UPJOHN COMPANY | Azabicyclic compounds for the treatment of disease |
US6858613B2 (en) * | 2002-02-19 | 2005-02-22 | Pfizer Inc. | Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease |
WO2003072578A1 (en) * | 2002-02-20 | 2003-09-04 | Pharmacia & Upjohn Company | Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
JP2006506395A (ja) * | 2002-11-01 | 2006-02-23 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | CNS疾患の治療のための、α7ニコチンアゴニスト活性及び5HT3アンタゴニスト活性を有する化合物 |
GB201421161D0 (en) * | 2014-11-28 | 2015-01-14 | Ge Healthcare As | Metal complex formulations |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
JPS5936675A (ja) * | 1982-07-13 | 1984-02-28 | サンド・アクチエンゲゼルシヤフト | 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド |
DE3445377A1 (de) * | 1983-12-23 | 1985-07-04 | Sandoz-Patent-GmbH, 7850 Lörrach | Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen |
EP0189002B1 (en) * | 1984-12-20 | 1993-03-03 | Sandoz Ag | Treatment of gastrointestinal disorders using 5-ht3 antagonists |
CH667657A5 (de) * | 1985-01-07 | 1988-10-31 | Sandoz Ag | Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine. |
US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
DE3688296T2 (de) * | 1985-03-14 | 1993-11-04 | Beecham Group Plc | Arzneimittel zur behandlung von erbrechen. |
US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
DE3650772T2 (de) * | 1985-04-27 | 2003-04-03 | Hoffmann La Roche | Derivate von Indazole-3-carboxamide und -3-carboxylsäure |
ES2053451T3 (es) * | 1986-01-07 | 1994-08-01 | Beecham Group Plc | Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles. |
HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
DE3801659A1 (de) * | 1988-01-21 | 1989-07-27 | Boehringer Ingelheim Kg | Tetrahydropyridin - derivate |
CA1332151C (en) * | 1988-01-28 | 1994-09-27 | Roman Amrein | Use of a benzamide to treat cognitive disorder |
EP0342558B1 (en) * | 1988-05-16 | 1994-02-02 | G.D. Searle & Co. | 2-amino-4,5-methyleneadipic acid compounds for treatment of CNS disorders |
YU150489A (sh) * | 1989-08-10 | 1992-12-21 | W.L. Gore & Co. Gmbh. | Uređaj za ispitivanje odevnih predmeta na nepromočivost |
DE69029737T2 (de) * | 1989-10-16 | 1997-06-19 | Hem Pharma Corp | Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch-immunologischer fehlfunktion |
ATE108448T1 (de) * | 1990-05-11 | 1994-07-15 | Sankyo Co | Piperdinyloxy- und chinindidinyloxy- isoxazol- derivate, ihre herstellung und ihre therapeutische verwendung. |
-
1987
- 1987-12-16 AT AT93201171T patent/ATE152623T1/de not_active IP Right Cessation
- 1987-12-16 EP EP87311079A patent/EP0279990B1/en not_active Expired - Lifetime
- 1987-12-16 US US07/133,885 patent/US4985437A/en not_active Expired - Lifetime
- 1987-12-16 DE DE3752062T patent/DE3752062T2/de not_active Expired - Lifetime
- 1987-12-16 EP EP19930200775 patent/EP0551963A3/en not_active Withdrawn
- 1987-12-16 AT AT87311079T patent/ATE124865T1/de not_active IP Right Cessation
- 1987-12-16 DE DE3751404T patent/DE3751404T2/de not_active Expired - Lifetime
- 1987-12-16 JP JP62318458A patent/JP2608079B2/ja not_active Expired - Lifetime
- 1987-12-16 EP EP93201171A patent/EP0559297B1/en not_active Expired - Lifetime
- 1987-12-16 ES ES87311079T patent/ES2074981T3/es not_active Expired - Lifetime
-
1995
- 1995-09-13 GR GR950402486T patent/GR3017369T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3752062T2 (de) | 1997-09-11 |
DE3752062D1 (de) | 1997-06-12 |
ATE152623T1 (de) | 1997-05-15 |
EP0559297B1 (en) | 1997-05-07 |
EP0559297A1 (en) | 1993-09-08 |
DE3751404D1 (de) | 1995-08-17 |
EP0279990A2 (en) | 1988-08-31 |
US4985437A (en) | 1991-01-15 |
EP0551963A2 (en) | 1993-07-21 |
EP0551963A3 (en) | 1993-09-01 |
DE3751404T2 (de) | 1995-12-21 |
EP0279990B1 (en) | 1995-07-12 |
ATE124865T1 (de) | 1995-07-15 |
JP2608079B2 (ja) | 1997-05-07 |
EP0279990A3 (en) | 1990-11-28 |
GR3017369T3 (en) | 1995-12-31 |
JPS63277623A (ja) | 1988-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2074981T3 (es) | Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos. | |
EA199700156A1 (ru) | Производные индола как антагонисты рецептора 5-нт | |
FI931370A (fi) | Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring | |
ATE162521T1 (de) | 3-aminopiperidine derivate und verwandete stickstoff enthaltende heterocyclische verbindungen | |
BR9206500A (pt) | Heterociclos contendo, nitrogênio tricíclico condensado como antagonistas de substancia receptora P | |
DE3772789D1 (de) | Halogen enthaltende heterozyklische verbindungen und diese enthaltende fluessigkristalline zusammensetzungen. | |
ES2065691T3 (es) | Derivados de quinuclidina. | |
CA2123403A1 (en) | Acyclic ethylenediamine derivatives as substance p receptor antagonists | |
NO964236L (no) | Anvendelse av serotonin-antagonister (5HT3) for behandling av fibromyalgi | |
ES2113368T3 (es) | Antagonistas de serotonina. | |
DE3650647D1 (de) | Arzneimittel zur Behandlung von Anxietas | |
DE3788057T2 (de) | Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen. | |
NO871861L (no) | Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer. | |
ATE182467T1 (de) | Verwendung von antagonisten oder partiellen agonisten am 5-ht 1a-rezeptor zur behandlung und prävention von kognitiven störungen | |
FI100240B (fi) | Menetelmä keskushermostoon vaikuttavien substituoitujen syklohekseenie n valmistamiseksi | |
ES2059399T3 (es) | Uso de derivados heterociclicos en la fabricacion de medicamentos. | |
BG103089A (en) | Indoline derivatives useful as 5-ht-2c-receptor antagonists | |
DE68926222D1 (de) | Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 279990 Country of ref document: ES |